Table 3.
Mortality analysis of the main group.
| Variable | Deceased 53 patients (75.7%) |
Survivors 17 patients (24.3%) |
p |
|---|---|---|---|
| Age (years) | 62.1±3 | 61.4±4 | 0.65 |
| WBC (×109/L) | 14.98±10.52 | 14.77±10.55 | 0.95 |
| PLT (×109/L) | 94.92±70.57 | 157.75±96.73 | 0.01 |
| Creatinine (mg/dL) | 1.67 (0.9–3.27) | 1.22 (0.7–2.64) | 0.79 |
| CRP (mg/dL) | 4.85±4.06 | 4.55±3.25 | 0.81 |
| ALT (U/L) | 37.5 (20–100.25) | 38.5 (20–62.5) | 0.89 |
| AST (U/L) | 90 (42.75–252.75) | 67.5 (31.75–122.75) | 0.74 |
| Bilirubin (mg/dL) | 4.15 (1.99–9.15) | 1.44 (0.88–1.89) | 0.001 |
| INR | 2.41±0.83 | 2.04±1.37 | 0.38 |
| HE, n (%) | 34 (64.2) | 4 (23.5) | 0.003 |
| Ascites, n (%) | 38 (71.7) | 6 (40) | 0.02 |
| SBP, n (%) | 12 (22.6) | 0 | 0.05 |
| Bacterial infections, n (%) | 31 (58.5) | 8 (47.1) | 0.40 |
| SP (mmHg) | 97.5±20.64 | 113.5±19.5 | 0.01 |
| NLR | 12.6±9.81 | 8.63±7.8 | 0.17 |
| MELD score | 27±8.35 | 20.5±8.17 | 0.01 |
| Child-Turcotte-Pugh score | 11.4±2.18 | 8.41±1.5 | <0.001 |
| ACLF | 49 (92.5) | 9 (52.9) | 0.001 |
| ACLF grade 1 | 0 | 2 (22.2) | <0.001 |
| ACLF grade 2 | 3 (6.1) | 5 (55.6) | |
| ACLF grade 3 | 46 (93.9) | 2 (22.2) | |
| Liver failure, n (%) | 24 (49) | 8 (66.7) | 0.27 |
| Renal failure, n (%) | 46 (93.9) | 8 (66.7) | 0.02 |
| Cerebral failure, n (%) | 30 (61.2) | 2 (16.7) | 0.006 |
| Coagulation failure, n (%) | 21 (42.9) | 0 | 0.005 |
| Circulation failure, n (%) | 45 (91.8) | 4 (33.3) | <0.001 |
| Respiratory failure, n (%) | 41 (85.4) | 7 (50) | 0.01 |
NLR: neutrophil-to-lymphocyte count; WBC: white blood cells; PLT: platelets; CRP: C-reactive protein; ALT: alanine aminotransferase; AST: aspartate aminotransferase; ACLF: acute-on-chronic liver failure; MELD: model for end-stage liver disease; HE: hepatic encephalopathy; SP: systolic blood pressure; SBP: spontaneous bacterial peritonitis; INR: international normalized ratio; Note: the bold values denote statistical significance.